🔎 Trials Near Me

Akèy › Kansè pwostat rezistan a kastasyon › Texas

Etid klinik pou Kansè pwostat rezistan a kastasyon nan Texas

7 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Texas Oncology, Austin
  • UT Southwestern Medical Center, Dallas
  • Houston Metro Urology, Houston
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • UT Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
  • Michael E DeBakey VA Medical Center, Houston
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  • START Dallas-Fort Worth, Fort Worth
  • NEXT Houston, Houston
  • NEXT Oncology, San Antonio
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07719361

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

  • Investigational Site Number: 401, Houston
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05997615

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • Mary Crowley Cancer Research, Dallas
  • University of Texas Southwestern Medical Center, Dallas
  • Houston Methodist Hospital, Houston
Ap rekriteFaz 1
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • University of Texas Health Science Center at Houston, Houston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

  • NEXT Oncology, San Antonio
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 10, 2026 · NCT06067841

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.